Palumbo Wealth Management LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1846310 GREAT NECK, NY

Position in DSGN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$759,781

+$109,025 QoQ

Shares Held

71,408

+2.9% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Palumbo Wealth Management LLC holds $15,072,882 across 31 Biotechnology names. DSGN ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNTH	Dianthus Therapeutics, Inc. /DE/	10,360	$869,411
2	SNDX	Syndax Pharmaceuticals Inc	37,183	$868,594
3	IDYA	IDEAYA Biosciences, Inc.	22,888	$762,628
4	DSGN	Design Therapeutics, Inc. This page	71,408	$759,781
5	NVAX	Novavax Inc	92,111	$749,783
6	NKTR	Nektar Therapeutics	10,173	$731,947
7	DFTX	Definium Therapeutics, Inc.	37,966	$717,557
8	IMNM	Immunome Inc.	32,051	$700,955

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$759,781	71,408	+2.9%	Shares	Defined	2026-05-12
2025-12-31	$650,756	69,377	+33.2%	Shares	Sole	2026-01-21
2025-09-30	$392,169	52,081	-14.0%	Shares	Sole	2025-11-10
2025-06-30	$204,070	60,555	+3.9%	Shares	Sole	2025-07-15
2025-03-31	$224,953	58,278	+6.5%	Shares	Sole	2025-04-22
2024-12-31	$337,474	54,696	+48.7%	Shares	Sole	2025-01-30
2024-09-30	$197,844	36,774	+11.3%	Shares	Sole	2024-10-28
2024-06-30	$110,730	33,054	+94.8%	Shares	Sole	2024-08-02
2024-03-31	$68,397	16,972	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.